← Back to Search

Electrical Stimulation

Two Unit TENS for Period Pain

N/A

Waitlist Available

Led By Todd Schroeder, PhD

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month

Awards & highlights

Study Summary

This trial will test whether a TENS device can help relieve pain for people with primary dysmenorrhea, by comparing pain levels with and without the device.

Eligible Conditions

Period Pain

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Analgesic effects of TENS on primary dysmenorrhea.

Secondary outcome measures

Change in analgesic pill consumption during menstruation

Other outcome measures

The surface area of TENS pain relief

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Two Unit TENSExperimental Treatment1 Intervention

Participants will use a two-unit TENS set-up where the TENS unit has 4 channels.

Group II: One Unit TENSExperimental Treatment1 Intervention

Participants will use one-unit TENS set-up where the TENS unit has 2 channels.

Group III: ControlActive Control1 Intervention

During the control condition cycle (no TENS), participants will refrain from using or taking other analgesics, besides ibuprofen.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

One Unit TENS

2022

N/A

~50

Two Unit TENS

2022

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor

905 Previous Clinical Trials

1,596,234 Total Patients Enrolled

Todd Schroeder, PhDPrincipal InvestigatorAssociated Professor

3 Previous Clinical Trials

119 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for participants in this research endeavor?

"The clinical trial portal indicates that this research endeavour is actively seeking volunteers. It was initially published on March 1st 2022, with its most recent edit occurring on September 20th 2022."

Answered by AI

Who can qualify to be a participant of this investigation?

"To meet the criteria for this trial, applicants must present with dysmenorrhea and be aged between 18 - 35. This investigation is looking to enroll a total of 60 individuals in its research."

Answered by AI

Is the age of enrolment for this clinical inquiry restricted to adults only?

"This clinical trial only includes participants aged 18 to 35. However, there are an additional 11 studies for patients below and above this age threshold."

Answered by AI

How many participants are currently involved in this research project?

"Affirmative. Clinicaltrials.gov records confirm that this research protocol, which went live on the 1st of March 2022, is currently recruiting volunteers. Sixty participants need to be sourced from one centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Role of Transcutaneous Electrical Nerve Stimulation (TENS) for Menstrual Pain Relief

Todd Schroeder 2022. "The Role of Transcutaneous Electrical Nerve Stimulation (TENS) for Menstrual Pain Relief". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05178589.